Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France
Infectious Diseases Now(2022)
摘要
•Nationwide study, using data from Point Prevalance studies in acute care hospitals.•Decrease in carbapenem and aminoglycoside use between 2012 and 2017, in patients with an ESBL-producing Enterobacteriaceae HAI:•Treatment durations remain longer than recommended.•Results can serve to direct future efforts in antimicrobial stewardship.
更多查看译文
关键词
Enterobacteriaceae,Extended-spectrum beta-lactamase,Antibiotics,Point prevalence survey,Healthcare-associated infections
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要